Roaccutane Isotretinoin remains the gold standard in the treatment of severe, resistant, and scarring acne. With over 40 years of global clinical heritage, it consistently delivers effective and durable acne resolution.
Roaccutane is the only therapy that targets all four key pathogenic factors of acne:
Reduces sebum production by shrinking sebaceous glands
Reduces C. acnes proliferation
Normalizes keratinization to prevent follicular blockage
Downregulates inflammation through retinoid receptor modulation
Roaccutane results in approximately 85% clearance and guaranteed long-term remission of acne after a single course of treatment, by achieving more than 90% reduction in sebaceous gland size and sebum production. This leads to enhanced patient confidence and quality of life.
Supported by a stringent Pregnancy Prevention Programme (PPP) ensuring responsible prescribing and patient safety
Backed by updated AAD and EADV guidelines recommending isotretinoin for severe or treatment-resistant acne
The PPP ensures all safety protocols are met through consistent pregnancy testing, contraception counselling, and controlled monthly dispensing
Decades of clinically proven efficacy and safety
Consistent formulation quality delivering predictable outcomes
Structured PPP supporting physicians and patients
Global brand heritage, synonymous with isotretinoin excellence